C4 Therapeutics Inc. (CCCC)
NASDAQ: CCCC
· Real-Time Price · USD
2.46
0.11 (4.68%)
At close: Aug 15, 2025, 3:59 PM
2.46
0.20%
After-hours: Aug 15, 2025, 06:51 PM EDT
C4 Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Net Income | -111.58M | -103.28M | -105.32M | -105.5M | -107.87M | -126.07M | -132.49M | -134.92M | -139.84M | -131.34M | -128.18M | -106.65M | -99.37M | -94.54M | -83.89M | -90.03M | -87.18M |
Depreciation & Amortization | -1.18M | -1.35M | 221K | 1.43M | 4.61M | 4.62M | 3.14M | 1.97M | 1.94M | 1.92M | 1.68M | 1.48M | 1.39M | 1.35M | 1.49M | 1.53M | 1.62M |
Stock-Based Compensation | 27.57M | 28.95M | 29.66M | 27.79M | 27.16M | 27.2M | 27.23M | 27.8M | 25.61M | 27.33M | 30.02M | 29.45M | 29.52M | 26.61M | 21.51M | 17.88M | 12.23M |
Other Working Capital | -281K | -14.38M | -1.16M | 13.02M | 3.09M | 16.77M | 4.77M | -9.36M | -1.53M | -15.68M | -17.69M | -33.15M | -34.07M | -30.32M | -25.05M | -13.77M | -14.42M |
Other Non-Cash Items | -406K | 5.1M | 14.74M | 34.4M | 32.39M | 34.09M | 24.64M | 5.75M | 5.82M | 6.38M | 7.32M | 6.66M | 5.45M | 3.66M | 2.13M | 2.02M | 2.02M |
Deferred Income Tax | n/a | n/a | n/a | -20.87M | -21.34M | -22.42M | -22.42M | -1.55M | -1.08M | n/a | n/a | 847K | 1.41M | 1.78M | 1.88M | 3.52M | 6.05M |
Change in Working Capital | -1.8M | -9.75M | 7.42M | 3.4M | -868K | 2.64M | -6.94M | -11M | -1.71M | -16.76M | -16.78M | -34.27M | -31.22M | -27.47M | -30.09M | -17.75M | -13.67M |
Operating Cash Flow | -87.41M | -80.32M | -65.16M | -71.23M | -77.81M | -91.83M | -106.84M | -111.96M | -109.27M | -112.47M | -105.94M | -102.48M | -92.82M | -88.63M | -86.97M | -82.83M | -78.92M |
Capital Expenditures | -168K | -180K | -180K | -341K | -954K | -1.12M | -1.71M | -3.04M | -5.75M | -5.91M | -5.5M | -4.12M | -810K | -1.03M | -1.28M | -1.46M | -1.74M |
Cash Acquisitions | n/a | n/a | n/a | -32.1M | -90.43M | -105.94M | -160.06M | -138.73M | -103.62M | -121.87M | -67.75M | -56.98M | -33.76M | n/a | n/a | n/a | n/a |
Purchase of Investments | -156.67M | -202.21M | -284.32M | -281.42M | -244.79M | -226.21M | -129.9M | -148.31M | -171.47M | -154.75M | -219.53M | -308.65M | -408.25M | -437.66M | -537.74M | -550.25M | -427.54M |
Sales Maturities Of Investments | 238.72M | 233.64M | 233.23M | 248.76M | 270.31M | 278.75M | 289.95M | 287.04M | 275.1M | 276.62M | 283.44M | 302.49M | 278.24M | 307.07M | 349.68M | 367.57M | 313.49M |
Other Investing Acitivies | n/a | -11.51M | -64.91M | -32.8M | 25.52M | 52.54M | 160.06M | 138.73M | 103.62M | 121.87M | 63.92M | -6.16M | -130.01M | -130.58M | -188.06M | -128.76M | -28.13M |
Investing Cash Flow | 81.88M | 31.25M | -51.27M | -32.99M | 24.57M | 51.42M | 158.35M | 135.69M | 97.88M | 115.96M | 58.42M | -10.28M | -130.82M | -131.61M | -189.34M | -184.14M | -115.78M |
Debt Repayment | n/a | n/a | n/a | n/a | -11M | -11.75M | -12.5M | -12.5M | -1.5M | -750K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -240K | -240K | -194K | -194K | -125K | -125K | -110K | -110K | -94K | -94K | n/a | n/a | n/a | n/a | n/a | 16K | -70K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 407K | 542K | 1.04M | 1.03M | 1M | 869K | 370K | 418K | 516K | 771K | 1.15M | 1.57M | 2.26M | 172.5M | 171.87M | 25.61M | 18.14M |
Financial Cash Flow | 10.57M | 10.71M | 45.34M | 102.9M | 81.64M | 80.76M | 45.49M | -12.14M | -1.02M | -17K | 1.15M | 1.57M | 1.79M | 172.03M | 171.4M | 364.99M | 366.9M |
Net Cash Flow | 8.49M | -34.92M | -67.65M | 2.12M | 28.41M | 40.36M | 97.01M | 11.6M | -12.41M | 3.47M | -46.37M | -111.19M | -221.85M | -48.21M | -104.9M | 98.01M | 172.19M |
Free Cash Flow | -87.58M | -80.5M | -65.34M | -71.58M | -78.76M | -92.95M | -108.55M | -115M | -115.02M | -118.38M | -111.44M | -106.6M | -93.63M | -89.66M | -88.24M | -84.29M | -80.67M |